About Kaio Therapy
Kaio Therapy is a company based in Raleigh (United States) founded in 2012. Kaio Therapy has raised $3.91 million across 3 funding rounds. Kaio Therapy offers products and services including IAHT, Nanoparticle Formulation, and AMF Device. Kaio Therapy operates in a competitive market with competitors including Liquidia, Sirnaomics, Acorda, NanoSyrinx and Genedit, among others.
- Headquarter Raleigh, United States
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Kaio Therapy, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.91 M (USD)
in 3 rounds
-
Latest Funding Round
$897.2 K (USD), Seed
Nov 09, 2020
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kaio Therapy
Kaio Therapy offers a comprehensive portfolio of products and services, including IAHT, Nanoparticle Formulation, and AMF Device.
Uses nanoparticles and magnetic fields to heat and destroy cancer cells
Enables targeted heat delivery for immune activation in tumors
Generates magnetic fields to induce controlled fever in cancer cells
Funding Insights of Kaio Therapy
Kaio Therapy has successfully raised a total of $3.91M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $897.2 thousand completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Kaio Therapy
Investment portfolio details for Kaio Therapy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kaio Therapy
Detailed financials for Kaio Therapy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kaio Therapy Comparisons
Peer comparison for Kaio Therapy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kaio Therapy
Kaio Therapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Liquidia, Sirnaomics, Acorda, NanoSyrinx and Genedit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Engineered particles & films for life and material sciences applications
|
|
| Locked | Locked | Locked |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| Locked | Locked | Locked |
Engaged in the development and commercialization of therapies that improve neurological function.
|
|
| Locked | Locked | Locked |
Drug delivery systems to cell interiors are developed via nanosyringes.
|
|
| Locked | Locked | Locked |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| Locked | Locked | Locked |
Thermal therapy for benign prostatic hyperplasia (BPH) is developed.
|
Detailed competitors of Kaio Therapy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kaio Therapy
Complete news archive for Kaio Therapy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kaio Therapy
Kaio Therapy was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Kaio Therapy is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Kaio Therapy is a funded company, having raised a total of $3.91M across 3 funding rounds to date.
Kaio Therapy was founded in 2012 in Raleigh, United States, within the biotechnology sector focused on oncology. A hyperthermia-based platform is developed, featuring the Immune Activating Heat Therapy device as a drug-device combination. Magnetite Cationic Liposome nanoparticles are injected into tumor sites and exposed to alternating magnetic fields to generate localized heat, aiming to enhance immune responses at the tumor. Operations center on advancing this technology for cancer treatment.
Kaio Therapy's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
Kaio Therapy offers IAHT, Nanoparticle Formulation, and AMF Device.